Biaxially oriented polypropylene film production technology developed by MOBIL OIL CORP. will be used by DAICEL CHEMICAL INDUSTRIES, LTD. in a plant that is scheduled for operation in the third quarter of 2000. The license agreement, limited to sales in Japan, covers coated as well as uncoated and white opaque BOPP films for packaging and labeling applications. Until DCI starts production, it will distribute locally BOPP films manufactured by MOBIL CHEMICAL CO.'s Pittsford, New York- headquartered films division.
In time, all respiratory and allergy products developed by RHONE-POULENC RORER INC. will be marketed in Japan by FUJISAWA-FISONS K.K. rather than FUJISAWA PHARMACEUTICAL CO., LTD. alone. Jointly owned by the Collegeville, Pennsylvania global pharmaceutical company, Fujisawa- Fisons previously assumed responsibility for promoting Intal (cromolyn sodium) to general practitioners. Now, it is handling sales to hospitals. Fujisawa Pharmaceutical gained this right in 1971 under a distribution agreement with FISONS PLC, now part of Rhone-Poulenc Rorer.
An exchange rate of ¥132=$1.00 was used in this report.